The Biomedical Translation Bridge (BTB) Program is an initiative of the Medical Research Future Fund, providing up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage. The BTB program is operated by MTPConnect in partnership with BioCurate, UniQuest, the Medical Device Partnering Program and the Bridge and BridgeTech programs.
A national program of information sessions will be launched in Melbourne on Monday 13 May 2019. Join BioCurate CEO Dr C. Glenn Begley and representatives from MTPConnect, UniQuest, the Medical Device Partnering Program and the Bridge and BridgeTech programs to find out if the BTB Program could support your life sciences innovation.
For more information about the national program of information sessions, email email@example.com or keep an eye out on the MTPConnect website.
Click here to register for the Melbourne information session.